Vaccine Safety Research: Critical Findings From Doctors and Investigators

In the current health landscape, mainstream communications often provide a singular perspective on immunization. However, a significant body of work exists that suggests a need for a more nuanced discussion. Over 60 credentialed physicians, researchers, and investigators have documented specific concerns regarding vaccine safety that frequently do not reach the broader public. These findings are the result of years of dedicated research, interviews, and documentary evidence gathered by journalists Ty and Charlene Bollinger.

The scope of this research is broad and detailed. It encompasses the toxicology of specific ingredients and the methodologies used in safety trials. It also examines data that was removed prior to publication and the unique legal framework that governs vaccine injury. Engaging with this information does not necessarily mean rejecting the concept of vaccination. Instead, it involves understanding what the evidence actually shows so that individuals can make informed decisions based on a complete data set.

Key findings from independent medical research

The documentation provided by these medical professionals highlights several critical areas where current practices and safety standards are being questioned. These points serve as the foundation for a deeper investigation into how vaccines are manufactured, tested, and regulated.

• The aluminum dose administered in the newborn hepatitis B vaccine exceeds the FDA’s own parenteral safety limits when calculated against a newborn’s body weight.
• During the Gardasil HPV vaccine trials, the placebo used was not an inert saline solution but rather a solution containing the aluminum adjuvant.
• A senior scientist at the CDC disclosed that data indicating a link between MMR vaccination and autism in African-American boys was removed from a study after the analysis phase was completed.
• Since the passage of the National Childhood Vaccine Injury Act in 1986, vaccine manufacturers have held complete legal immunity from injury lawsuits.
• There are currently no safety studies that have tested the effects of giving multiple vaccines simultaneously with multiple adjuvants to a single patient.
• Research indicates that natural infection with certain childhood diseases can confer broader and longer-lasting immunity than vaccination.
• Evidence suggests that individuals who experience natural childhood infections may have lower rates of chronic disease in adulthood.

The trial design problem in clinical research

One of the most significant concerns raised by medical professionals involves the way clinical trials are structured. Dr. Toni Bark, a physician and former pediatric emergency department director, has spent considerable time reviewing the Phase 3 clinical trial data for the Gardasil vaccine. Her findings point to a fundamental issue in the study’s design regarding the “control” group.

In a standard scientific trial, the control group should receive an inert substance, such as a saline solution, to provide a clear baseline for safety. However, in the Gardasil trials, the placebo was a solution containing the same aluminum adjuvant used in the vaccine itself. This is a critical distinction in research methodology. When the control group receives a pharmacologically active substance that is also present in the test group, the trial may fail to detect adverse events caused by that specific substance.

Implications of non-inert placebos

The results of the Gardasil trial showed that adverse event rates were similar in both the vaccine group and the placebo group. In mainstream health communications, this was cited as evidence of the vaccine’s safety. Dr. Bark argues that this interpretation is flawed. She suggests that the trial was designed in a way that made any harm related to the aluminum adjuvant invisible from the start. If both groups are reacting to the same ingredient, the “difference” between the groups remains negligible, even if both groups are experiencing adverse effects.

What is actually in vaccines and why it matters

To understand the safety profile of any medical intervention, one must look closely at its components. Vaccines are composed of active ingredients, known as antigens, and a variety of additional substances. These include adjuvants, preservatives, stabilizers, and residual compounds from the manufacturing process. The method of delivery is also a key factor in how the body processes these materials.

Vaccines are typically injected directly into muscle or subcutaneous tissue. This delivery method bypasses the digestive and mucosal immune systems. These systems act as natural filters and processing centers for foreign material when it is taken orally or inhaled. By bypassing these initial defenses, the ingredients in vaccines enter the body in a way that the human immune system does not typically encounter in nature.

The role and behavior of aluminum adjuvants

Aluminum salts are the most widely used adjuvants in modern vaccines, including those for hepatitis B, HPV, and DTaP. Their primary function is to trigger localized inflammation. This inflammation is intended to amplify the immune system’s response to the antigen, theoretically making the vaccine more effective. However, the safety of this process is a subject of intense study.

Researchers Dr. Christopher Shaw and Dr. Lucija Tomljenovic at the University of British Columbia have conducted extensive work on this topic. Their research found that injected aluminum behaves quite differently from aluminum that is ingested through food or water. Injected aluminum can be transported by immune cells throughout the body and has been shown to cross the blood-brain barrier. This raises questions about the long-term neurological impact of cumulative aluminum exposure through the vaccination schedule.

FDA limits and newborn exposure

The FDA has established a maximum parenteral aluminum limit of 25 micrograms per kilogram of body weight per day. This limit is intended to prevent toxicity in patients receiving intravenous fluids. Multiple independent researchers have applied this standard to the newborn vaccination schedule. They calculated that the aluminum content in the hepatitis B vaccine, which is often given on the first day of life, substantially exceeds this safety limit for an average newborn. This discrepancy between established safety limits and actual practice is a primary concern for many healthcare providers.

The history and impact of thimerosal

Thimerosal is a preservative that contains approximately 50% ethylmercury by weight. In 2003, health authorities announced that thimerosal was being removed from childhood vaccines. While this was presented as a significant safety move, the details of the transition are complex. The preservative was removed from three specific childhood vaccines, but the overall exposure levels for some populations did not necessarily decrease.

In the same year that thimerosal was being phased out of certain products, the CDC added flu vaccines to the recommended schedule for both pregnant women and young children. At that time, the majority of flu vaccines contained high doses of thimerosal. The net result of this policy shift was that fetal exposure to ethylmercury began to occur for the first time. This exposure happened during the first and second trimesters, which are the most neurologically vulnerable points in human development.

Challenges faced by researchers in the field

When researchers publish findings that are critical of the current vaccine program or suggest potential risks, they often face significant professional and personal challenges. Several high-profile cases illustrate the difficulties of maintaining scientific transparency in this field. These cases involve allegations of data suppression and the professional marginalization of scientists who report concerning data.

The disclosure of Dr. William Thompson

In 2014, Dr. William Thompson, a senior scientist at the CDC, made a public disclosure that garnered significant attention. He stated that he and his colleagues had identified a statistically significant association between the timing of the MMR vaccination and autism diagnoses in African-American boys. Specifically, the data suggested a higher risk for those vaccinated before 36 months of age.

Dr. Thompson alleged that this specific finding was removed from the final published version of the study. He claimed that the study population criteria were altered after the analysis was already complete to obscure the results. Thompson retained the original, unedited documents and submitted them to a member of the U.S. Congress. To date, the CDC has not conducted a formal investigation into these allegations, and the original study has not been retracted or corrected.

The case of Dr. Andrew Wakefield

Dr. Andrew Wakefield is perhaps the most well-known figure in the debate over vaccine safety. In 1998, he and several colleagues published a case series in The Lancet. The paper described gastrointestinal disease and developmental regression in twelve children. The parents of these children had linked the onset of these symptoms to the MMR vaccination.

The paper was retracted in 2010, and Dr. Wakefield subsequently lost his medical license. However, Wakefield contends that the retraction was the result of a campaign funded by interests within the pharmaceutical industry. He maintains that the clinical findings of the study — specifically the presence of a unique form of bowel disease that responded to treatment — were never addressed on their scientific merits by the medical establishment.

Research on the chickenpox vaccine and shingles

Dr. Gary Goldman provides another example of the complexities involved in post-licensure vaccine monitoring. He was contracted by the CDC to analyze data following the introduction of the chickenpox vaccine. His research led to an unexpected finding regarding the adult population.

Dr. Goldman found that by suppressing chickenpox in children, the natural immune re-exposure that adults normally receive was being eliminated. This re-exposure serves as a natural “booster” that helps protect adults against shingles. His data indicated that shingles rates were rising in adults as a direct result of the childhood vaccination program. Following the report of these findings, his contract was not renewed. He eventually published his research independently to ensure the data was available to the public.

The legal and financial framework of vaccine injury

A unique aspect of the vaccine industry is the legal protection afforded to manufacturers. This framework was established by the National Childhood Vaccine Injury Act of 1986. This law fundamentally changed the way vaccine injuries are handled in the United States by removing the right of citizens to sue vaccine manufacturers in civil court for damages.

Instead of traditional litigation, all claims must go through the National Vaccine Injury Compensation Program (NVICP). This is a federal “no-fault” system. It is not funded by the pharmaceutical companies, but rather by a tax collected on every vaccine dose sold. Since its inception in 1986, the program has paid out over 4.5 billion dollars to families of individuals who have been injured by vaccines.

Manufacturer immunity and consumer costs

Because the compensation funds come from a consumer tax, vaccine manufacturers face no direct financial consequences when their products cause harm. This lack of financial liability is a significant departure from how other consumer products and pharmaceuticals are regulated. In most industries, the threat of litigation serves as an incentive for rigorous safety testing and product improvement.

The legal status of vaccines was further clarified by a 2011 Supreme Court decision in the case of Bruesewitz v. Wyeth. The court confirmed that vaccines fall into a legal category of products that are “unavoidably unsafe.” This legal finding exists in contrast to public health communications that describe vaccines as “very safe.” Furthermore, while the 1986 Act required the Department of Health and Human Services (DHHS) to conduct biennial safety reviews and report to Congress, a 2018 Freedom of Information request revealed that no such reports had been produced in 32 years.

The science of natural immunity

An important part of the discussion involves comparing vaccine-induced immunity with natural immunity. Historical data suggests that the decline in mortality from many infectious diseases began long before vaccines were introduced. Dr. Suzanne Humphries and Roman Bystrianyk documented this in their book, “Dissolving Illusions.”

By compiling official vital statistics from the U.S. and the UK, they showed that deaths from measles, pertussis, and diphtheria had fallen by 90% or more prior to the widespread use of vaccines for those diseases. The data suggests that improvements in sanitation, nutrition, and general living conditions were the primary drivers of this decline. This historical context is often missing from the standard narrative of medical progress.

Long-term benefits of natural infection

Natural infection with diseases such as measles or chickenpox typically confers lifelong immunity. Furthermore, some research suggests that these infections provide broader health benefits. Studies cited in this body of work indicate that children who recover from natural measles may have lower rates of certain cancers and atopic conditions, such as asthma and allergies, later in life.

The proposed mechanism for this is that natural infection trains the entire immune system. This includes both the innate and adaptive branches, as well as the mucosal immune system. When a vaccine is injected, it bypasses these integrated systems, which may result in a different and potentially less comprehensive immune profile compared to natural recovery.

Actionable steps for families and parents

Navigating the complexities of vaccine safety can be overwhelming for parents and patients. However, there are resources and legal avenues available for those who wish to take a more active role in their healthcare decisions. Understanding how to report adverse events and knowing your legal rights are essential steps.

Utilizing the VAERS database

The Vaccine Adverse Event Reporting System (VAERS) is a national database managed by the CDC and FDA. It is designed to act as an early warning system for potential safety issues. It is important to note that anyone, including parents and patients, can file a report if they suspect a vaccine has caused an adverse reaction. Healthcare providers are not legally required to file these reports.

Independent researchers estimate that VAERS may only capture between 1% and 10% of actual adverse events. This underreporting makes it difficult to establish an accurate safety profile. By filing a report, you contribute to the “safety signal” data that independent researchers use to monitor vaccine performance in the real world. Creating a formal record is a vital part of maintaining medical transparency.

Understanding exemptions and informed consent

Informed consent is a fundamental principle of medical ethics. It implies that a patient or guardian has the right to understand the risks and benefits of a procedure and the right to refuse it. Attorney Allison Folmar and other legal experts have documented the arguments supporting parental rights in this area.

Depending on your location, various exemptions may be available, including medical, religious, or philosophical exemptions. While some states have moved to remove these options, legal challenges continue to be filed to protect the right to informed consent. Understanding the specific laws in your area is a key part of the decision-making process.

Getting direct answers to your questions

The research surrounding vaccine safety is vast and highly technical. You do not have to navigate this body of work alone or spend hundreds of hours searching through documents to find the information you need. Whether you have a question about a specific ingredient, a particular clinical study, or the legal options available to you as a parent, there is a more efficient way to get answers.

You can put your questions directly to the knowledge base at tryit.tv. This service provides direct answers drawn from this research and other authoritative sources in a matter of seconds. It is designed to help you access the facts quickly so you can make the best decisions for your family’s health and well-being.